Related Experiment Video

Updated: Sep 13, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Pseudomonas thoracic empyema secondary to nosocomial rhinosinusitis

P Meyer1, J M Guerin, Y Habib

  • 1Medical Intensive Care Unit, Lariboisière's Hospital, Université Paris VII.

The European Respiratory Journal
|October 1, 1988
PubMed

Insights

Pseudomonas thoracic empyema can arise in patients with nasotracheal intubation. Untreated sinusitis may cause recurrent empyema, necessitating prompt diagnosis and treatment.

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Nasotracheal intubation is a common procedure in Intensive Care Units (ICUs).
  • Prolonged intubation can lead to complications such as paranasal sinusitis.
  • Sinusitis can serve as a reservoir for bacterial pathogens.

Observation:

  • Three cases of Pseudomonas thoracic empyema in nasotracheally intubated patients are presented.
  • Patients developed extensive necrotizing pulmonary lesions due to respiratory tract colonization.
  • Persistent or recurrent empyema was linked to undiagnosed or inadequately treated sinusitis.

Findings:

  • Pseudomonas aeruginosa identified as the causative agent in thoracic empyema.
  • Sinusitis acts as a potential primary source for empyema development.
  • Effective treatment involves pleural drainage, sinusitis management, and antibiotics.

Implications:

  • Highlights the importance of diagnosing and treating sinusitis in intubated patients.
  • Informs clinical decisions regarding the duration of nasotracheal intubation versus early tracheostomy.
  • Suggests a link between sinus health and the prevention of severe respiratory infections like empyema.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...